Rasph

Weber: EIC Accelerator Grant for Bed Hygiene, and What Came Next

October 14, 20262,108 words11 min

Hospital beds pass germs from one patient to the next, and in most hospitals they are still wiped down by hand. Weber Hospital Systems, a spin-off of a family machine builder in Zwaag in the north of the Netherlands, built a cabin in which two industrial robots clean a bed with steam while a separate unit lifts off the mattress and steams it on every side. No chemical cleaning agents are used. In the EIC Accelerator pilot's March 2020 cut-off, the European Commission selected the project, called VDS (Validated Disinfection System), as one of its COVID-19-related winners, with a grant only, according to the Commission's list of selected companies. The EU contribution was €1,885,129.75 towards a total cost of €2,693,042.50, according to CORDIS.

Six years on, the machine is certified, sold and running in hospitals in Denmark, Germany, the Netherlands, Switzerland and Norway, according to the company. The question this article tests is how far the result matches what the proposal promised: a 2 to 3% share of the global market for washer-disinfectors and €97.6 million in cumulative revenue by 2025.

€1.89MEU contribution to the VDS project
9Systems in service, per the company's reference list
6 LWater per bed, as Weber states it
€97.6MCumulative revenue promised by 2025; no figures public

Company file

Legal entity
Weber Hospital Systems B.V., KvK 70196745, active
Founded
30 November 2017
Headquarters
De Corantijn 4, Zwaag, Netherlands
Group
Part of Weber Machinebouw, a machine builder founded in 1959
People named in sources
Erik Sierkstra (managing director, per Yaskawa); Sander Hummeling (VDS coordinator, global sales director)
Products
VDS-IPx4, VDS-IPx6 and VDS-CT washer-disinfectors
Outside investors
None found; not in the EIC Fund portfolio
EIC project
VDS, March 2020 cut-off, grant only, June 2020 to May 2022
Staff and revenue
Not public

Where Weber Hospital Systems Stands Now

The company is active. The Dutch business register lists it as active, with the corporate purpose of developing, building, distributing and maintaining "Validated Disinfection Systems" for hospitals, according to OpenKvK. North Data shows balance sheets filed for every year from 2022 to 2025, the latest on 17 July 2026; the figures in them are not available free of charge, so equity, results and staff could not be verified. In October 2024 the company also registered as a foreign entity in Norway, where the Brønnøysund Register Centre records its founding date as 30 November 2017 and no bankruptcy.

Its website, rebuilt in 2026, now sells three machines: the VDS-IPx4 for beds that cannot go through a wash tunnel, the VDS-IPx6 for machine-washable beds, and the VDS-CT for carts and trolleys. It also offers custom automation such as bed storage, vertical bed lifts and robotics for sterile supply departments, and states that the company is certified to ISO 13485, the quality standard for medical device makers. Weber Hospital Systems has announced no funding round, and the company does not appear in any of the 16 pages of the EIC Fund's list of invested companies, which is consistent with its grant-only award.

The Technology: Steam at Three Centimetres

Hospitals disinfect beds in one of two ways: with chemicals, by hand or in a wash tunnel, or thermally. A Yaskawa case study describes how Weber's machine works. The bed is identified by a code that gives its make and model, then pushed into a washing cabin. A vacuum plate lifts the mattress, which passes through a "letterbox" where steam is sprayed onto it from all sides. Two Yaskawa GP25-12 robots with steam and air lances clean the frame, getting as close as possible so the steam does not lose heat, and compressed air blows the water off. According to the final CORDIS report, the steam is applied from 3 centimetres with a contact temperature of at least 85 degrees Celsius, and the program is identical every time, so the result can be validated.

The selling point is that steam carries very little water. Modern intensive care beds contain scales, alarms and Wi-Fi and are rated only IPX4, splash-proof, so they cannot go through the wash tunnels used for IPX6 beds. Weber claims its system is "the only one suitable for processing high-end IPX4 beds" and that it achieves a 5-log reduction, killing 99.999% of bacteria on bed and mattress surfaces, in the project's CORDIS Results in Brief. These are the company's statements; no independent study of the machine's effect on infection rates was found.

The specifications have moved since the proposal. The EIC application promised a six-minute cycle; the company's website now gives cycle times "from 7 minutes" for the VDS-IPx4, with 6 litres of water and 4.5 kW per cycle, and 35 litres and 7.1 kW for the VDS-IPx6.

What the EIC Project Promised, and What CORDIS Shows

VDS ran from 1 June 2020 to 31 May 2022. CORDIS lists Gereedschap Constructie Bureau Weber BV, at the same Zwaag address, as a linked third party with €243,244.75 of the grant; the Commission's selection list names only Weber Hospital Systems. The objective on CORDIS described VDS as a prototype and set out "system optimization, validation and certification, along with pre-commercialisation activities", plus targets of a 2 to 3% global market share, cumulative revenue of €97.6 million by 2025 and employment for 133 people.

The final report is specific on the technical work. It says the production "0-model" and its software were completed, the machine was certified as a medical device under the EU Medical Device Directive, the company's quality system was certified to ISO 13485, and Agidens Belgium validated it against ISO 15883-6. The project's results page lists two patent applications of 21 October 2020, one for a mattress disinfection device and one for a robot with an elongated steam head, which North Data also records. The report adds that the company was selling the VDS "in Denmark, Norway, Germany and Switzerland in particular", had signed distributors for the United Kingdom and Hungary, and expected "10 VDS machines in use" within 24 months.

  1. Production model and softwareDeliveredCompleted, per the CORDIS report; product line on sale on the company website.
  2. Medical device certification and ISO 13485DeliveredMDD certification and ISO 13485 per CORDIS; ISO 13485 also stated on the website.
  3. External validation (ISO 15883-6)DeliveredValidated by Agidens Belgium, per CORDIS.
  4. Six-minute cycle, under 12 L and 5 kWPartly6 L and 4.5 kW, but cycles now "from 7 minutes" on the website.
  5. 10 machines in use within 24 months of mid-2022Late8 by the end of 2024 and 9 in 2025 on the company's list; the tenth is planned for 2026.
  6. €97.6M cumulative revenue and 2 to 3% market share by 2025Not achievedNo revenue figure published; nine systems is far from that scale.
  7. 133 jobsNot achievedNo staff figure published by the company or the register.

The technical part of the plan was delivered on time, which was the bulk of what the grant paid for. The commercial targets were never announced as met, and the company's own installation count makes the revenue target implausible, so the project counts as partly delivered.

What Weber Has Achieved Since the Award

The machine has a longer history than the company. In 2014 Weber Machinebouw, normally a metalworking business, built a one-off bed cleaning line for Erasmus MC in Rotterdam, according to Yaskawa. In November 2015 the Dutch broadcaster NOS reported that Erasmus MC would clean all beds and mattresses in what it called the first fully robotic washing line, six minutes per bed and about 50,000 beds a year; NOS did not name the builder. "We are just simple machine builders from West Friesland and no disinfection specialists," Erik Sierkstra, named as managing director, told Yaskawa, which quotes him saying that the first three machines had been installed in Denmark. The case study is undated.

"With this bed washing machine, every bed is always exactly as clean as it should be."

Erik Sierkstra, managing director, Weber Hospital Systems, in a Yaskawa case study

In March 2021 Yorkshire-based Innova Care Concepts announced a partnership to bring the system to NHS and private hospitals in the UK, according to National Health Executive and Architects for Health. Neither names a UK hospital, and no UK installation appears on Weber's reference list.

That reference list names eight hospitals with ten systems: Nordsjællands Hospital in Hillerød (2019), two at Herlev Hospital near Copenhagen with automated storage for 120 beds (2020), Klinikum Stuttgart (2021), CHUV in Lausanne (2023), two at Erasmus MC and one at Sozialstiftung Bamberg (2024), Drammen Hospital in Norway (2025), and Kantonsspital Aarau, planned for 2026. CORDIS confirms machines in use in Denmark and Germany by May 2022, and Yaskawa confirms the first three in Denmark; searches of news and tender databases found no independent confirmation of the individual later sites.

A niche product, sold one hospital at a time

Nine systems in service and a tenth planned, across eight hospitals since 2019, is real business for a machine builder, and each one can serve a whole hospital. But it is a small fraction of a market the proposal put at €6.15 billion by 2028, and no figure for revenue, margin or staff has been made public.

Why Europe Should Care

About 4.3 million patients in EU/EEA hospitals get a healthcare-associated infection each year, and at least 20% of these are preventable through sustained infection control, according to the European Centre for Disease Prevention and Control's 2024 survey release; CIDRAP adds that 32% of the microorganisms found in documented cases were resistant to antimicrobials. Stronger infection prevention and control is one of the aims of the Council's 2023 recommendation on stepping up EU action against antimicrobial resistance. A European-made, chemical-free bed disinfection machine fits that agenda, and by design it uses no chemical disinfectants. What is missing is evidence that it lowers infection rates, which would be the strongest argument for buying one.

What the company said

A validated steam system for every type of bed, 2 to 3% of the world market, €97.6 million in revenue by 2025 and 133 jobs.

What the record shows

A certified machine, two patent applications, three product versions and nine systems in five countries by its own list. No revenue, staff or infection-outcome data is public.

The Verdict

Built and certified, still small

The EIC money did what Weber said it would on the engineering side: a prototype became a certified medical device that hospitals in five countries use. The business case in the proposal did not follow, at least not in public. With no accounts, staff figures or independent infection data available, the size of the business, and what it has done for patients, cannot be judged.

Weber Hospital Systems has not been asked for comment for this article. It is based entirely on public records, company statements and EU project data, linked throughout.

Industry

HealthMedical devices

Focus
  • Infection control devices
Technologies
  • Robotics
  • Disinfection technology
Keywords
  • Hospital beds
  • Healthcare-associated infections
  • Chemical-free cleaning
  • Mattresses
  • Steam disinfection

Start with the EIC Accelerator

Expert review for Step 1 and Step 2, suitability assessment and grant screening.

Eureka Network

Eureka Network offers multiple international collaborative R&D programs including Network Projects, Clusters, Eurostars, Globalstars, and Innowwide, with funding ranging from €50K to €6.75M per project depending on the specific program. The network focuses on market-driven innovation and deep-tech development across diverse technology sectors including ICT/Digital, Industrial/Manufacturing, Bio/Medical Technologies, Energy/Environment, Quantum, AI, and Circular Economy. Applicants include SMEs, large enterprises, research organizations, universities, and startups, with Eurostars specifically targeting R&D-performing SMEs.

EIC Transition

EIC Transition provides up to €2.5 million in funding to bridge the 'valley of death' between laboratory research and market deployment, focusing on technology maturation and validation. The program supports single legal entities or small consortia of 2-5 partners including SMEs, start-ups, spin-offs, and research organizations. Technology areas include Health/Medical Technologies, Green/Environmental Innovation, Digital/Microelectronics, Quantum Technologies, and AI/Robotics.

EIC STEP Scale-Up

EIC STEP Scale-Up offers substantial equity investments of €10-30 million for established deep-tech companies ready for hyper-growth and large-scale expansion. The program targets SMEs or small mid-caps with up to 499 employees who have secured pre-commitment from qualified investors. Focus areas include Digital & Deep Tech (Semiconductors, AI, Quantum), Clean Technologies for Net-Zero goals, and Biotechnologies.

EIC Pre-Accelerator

EIC Pre-Accelerator is a pilot program providing €300,000-€500,000 in funding for early-stage deep-tech development and preparation for the EIC Accelerator program. The initiative is exclusively available to single SMEs or small mid-caps from 'Widening countries' to support regional innovation development. The program covers deep-tech innovations across physical, biological, and digital domains.

EIC Advanced Innovation Challenges

EIC Advanced Innovation Challenges is a new pilot program offering €300,000 (Stage 1) and up to €2.5 million (Stage 2) for breakthrough deep-tech solutions through ARPA-style staged funding with demand-side integration. The program targets single entities or small consortia (2-3 partners) including SMEs, start-ups, and research organizations. Focus areas include Physical AI for autonomous robotics and New Approach Methodologies (NAMs) for animal-free biomedical testing, requiring TRL 4 entry with end-user commitment.

EIC Pathfinder

EIC Pathfinder offers up to €3 million for Open calls and up to €4 million for Challenge-based calls to support early-stage research and development with proof-of-principle validation. The program requires research consortia with a minimum of 3 partners from 3 different countries, including universities, research organizations, and SMEs. Technology focus areas include Health/Medical, Quantum Technologies, AI, Environmental/Energy, and Advanced Materials.

EIC Accelerator

EIC Accelerator provides flexible funding options including blended finance (€2.5M grant + €0.5M-€10M equity), grant-only (up to €2.5M), or equity-only arrangements for scale-up and market deployment of breakthrough innovations. The program targets SMEs, start-ups, and small mid-caps with up to 499 employees, with MedTech/Healthcare representing 35% of funded projects. Other technology areas include Biopharma, Energy, AI, Quantum, Aerospace, Advanced Materials, and Semiconductors.

Innovation Partnership

Innovation Partnership facilitates collaborative innovation between public and private sectors with typical funding of €1-5 million per project. The program supports cross-sectoral strategic technologies through public-private partnerships and consortia. Projects focus on addressing societal challenges through collaborative innovation approaches.

Innovation Fund

The EU Innovation Fund provides substantial funding of €7.5 million to €300 million for large-scale demonstration of innovative low-carbon technologies. The program targets clean energy, carbon capture, renewable energy, and energy storage technologies to accelerate the transition to a low-carbon economy. Applicants include large companies, consortia, and public entities capable of implementing large-scale demonstration projects.

Innovate UK

Innovate UK offers various programs with funding ranging from £25K to £10M depending on the specific initiative, supporting business-led innovation, collaborative R&D, and knowledge transfer. The organization funds projects across all sectors with particular focus on emerging technologies and supports UK-based businesses, research organizations, and universities. Programs are designed to drive economic growth through innovation and technology commercialization.

Industrial Partnership

Industrial Partnership provides €2-10 million in funding for industrial research and innovation partnerships focusing on manufacturing, industrial technologies, and digital transformation. The program supports industrial consortia and research organizations in developing collaborative solutions for industrial challenges. Projects aim to strengthen European industrial competitiveness through strategic partnerships.

Eurostars

Eurostars is a joint EU-Eureka program offering €50K-€500K for international R&D collaboration specifically led by SMEs. The program takes a bottom-up approach, accepting projects from all technology fields without predefined thematic restrictions. R&D-performing SMEs must lead the consortium and demonstrate significant R&D activities.

LIFE Programme

The LIFE Programme provides €1-10 million in funding for environmental protection, climate action, and nature conservation projects across the European Union. The program supports environmental technologies, climate adaptation strategies, and biodiversity conservation initiatives. Applicants include public authorities, private companies, NGOs, and research institutions working on environmental and climate challenges.

Neotec

Neotec is a Spanish program offering €250K-€1M in funding for technology-based business creation and development, supporting the growth of innovative Spanish SMEs and start-ups. The program covers all technology sectors and aims to strengthen Spain's technology ecosystem. Funding is specifically targeted at Spanish technology-based SMEs and start-ups to enhance their competitiveness and market presence.

Thematic Priorities

EU Thematic Priorities encompass various programs aligned with EU strategic priorities including green transition, digital transformation, health, and security initiatives. Funding amounts vary based on the specific program and call requirements, with projects designed to address key European challenges. Applicant eligibility varies by specific program and call, with different requirements for different thematic areas.
EIC AcceleratorBeneficiary Deep Dive#Weber Hospital Systems#VDS#hospital bed disinfection#healthcare-associated infections#steam disinfection#medical devices#Netherlands
Loading